Filing Details
- Accession Number:
- 0001127602-22-027061
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2022-12-08 11:37:36
- Reporting Period:
- 2022-11-30
- Accepted Time:
- 2022-12-08 11:37:36
- Original Submission Date:
- 2022-12-01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1000697 | Waters Corp | WAT | Laboratory Analytical Instruments (3826) | 133668640 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1184452 | Edward Conard | 34 Maple Street Milford MA 01757 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-11-30 | 4,000 | $88.71 | 75,283 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-11-30 | 1,059 | $334.70 | 74,224 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2022-11-30 | 4,000 | $0.00 | 4,000 | $88.71 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2014-01-02 | 2023-01-02 | No | 4 | M | Direct |
Footnotes
- This amendment corrects an administrative error in which the acquisition price of the stock acquired through the exercise of the listed options was incorrectly listed at $334.7000 instead of the correct price of $88.7100.
- These stock options, which were granted on January 2, 2013 and vested 1 year thereafter, were scheduled to expire on January 2, 2023.
- The sale reported on this Form 4 represents shares sold to cover tax withholding obligations in connection with the exercise and settlement of a grant of options. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.